Multiplex Biomarker Imaging Market Report
RA02124
Multiplex Biomarker Imaging Market , by Type (Instruments, Software, Services), Application (Research, Clinical Diagnostics), End Use (Translation Laboratories, Biopharmaceutical Companies, Academic Institutes), Imaging Technique (Immunohistochemistry (IHC) Assays, Fluorescent In-Situ Hybridization (FISH) Assays, Tissue Microarray (TMA) Assays): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global multiplex biomarker imaging market
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Multiplex Biomarker Imaging Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Multiplex Biomarker Imaging Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Multiplex Biomarker Imaging Market , By Distribution Channel
5.1. Overview
5.2 Instruments
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Software
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Services
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Research Dive Exclusive Insights
5.5.1 Market attractiveness
5.5.2 Competition heatmap
-
6. Multiplex Biomarker Imaging Market , By Device Type
6.1. Overview
6.2 Research
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Clinical Diagnostics
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Research Dive Exclusive Insights
6.4.1 Market attractiveness
6.4.2 Competition heatmap
-
7. Multiplex Biomarker Imaging Market , By Type
7.1. Overview
7.2 Translation Laboratories
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Biopharmaceutical Companies
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Academic Institutes
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Research Dive Exclusive Insights
7.5.1 Market attractiveness
7.5.2 Competition heatmap
-
8. Multiplex Biomarker Imaging Market , By Laboratory Type
8.1. Overview
8.2 Immunohistochemistry (IHC) Assays
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Fluorescent In-Situ Hybridization (FISH) Assays
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Tissue Microarray (TMA) Assays
8.4.1 Definition, key trends, growth factors, and opportunities
8.4.2 Market size analysis, by region, 2020-2027
8.4.3 Market share analysis, by country, 2020-2027
8.5 Research Dive Exclusive Insights
8.5.1 Market attractiveness
8.5.2 Competition heatmap
9. Multiplex Biomarker Imaging Market , By Region
9.1 North America
9.1.1 U.S
9.1.1.1 Market size analysis, By Distribution Channel, 2020-2027
9.1.1.2 Market size analysis, By Device Type, 2020-2027
9.1.1.3 Market size analysis, By Type, 2020-2027
9.1.1.4 Market size analysis, By Laboratory Type, 2020-2027
9.1.2 Canada
9.1.2.1 Market size analysis, By Distribution Channel, 2020-2027
9.1.2.2 Market size analysis, By Device Type, 2020-2027
9.1.2.3 Market size analysis, By Type, 2020-2027
9.1.2.4 Market size analysis, By Laboratory Type, 2020-2027
9.1.3 Mexico
9.1.3.1 Market size analysis, By Distribution Channel, 2020-2027
9.1.3.2 Market size analysis, By Device Type, 2020-2027
9.1.3.3 Market size analysis, By Type, 2020-2027
9.1.3.4 Market size analysis, By Laboratory Type, 2020-2027
9.1.4 Research Dive Exclusive Insights
9.1.4.1 Market attractiveness
9.1.4.2 Competition heatmap
9.2 Europe
9.2.1 Germany
9.2.1.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.1.2 Market size analysis, By Device Type, 2020-2027
9.2.1.3 Market size analysis, By Type, 2020-2027
9.2.1.4 Market size analysis, By Laboratory Type, 2020-2027
9.2.2 UK
9.2.2.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.2.2 Market size analysis, By Device Type, 2020-2027
9.2.2.3 Market size analysis, By Type, 2020-2027
9.2.2.4 Market size analysis, By Laboratory Type, 2020-2027
9.2.3 France
9.2.3.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.3.2 Market size analysis, By Device Type, 2020-2027
9.2.3.3 Market size analysis, By Type, 2020-2027
9.2.3.4 Market size analysis, By Laboratory Type, 2020-2027
9.2.4 Spain
9.2.4.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.4.2 Market size analysis, By Device Type, 2020-2027
9.2.4.3 Market size analysis, By Type, 2020-2027
9.2.4.4 Market size analysis, By Laboratory Type, 2020-2027
9.2.5 Italy
9.2.5.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.5.2 Market size analysis, By Device Type, 2020-2027
9.2.5.3 Market size analysis, By Type, 2020-2027
9.2.5.4 Market size analysis, By Laboratory Type, 2020-2027
9.2.6 Rest of Europe
9.2.6.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.6.2 Market size analysis, By Device Type, 2020-2027
9.2.6.3 Market size analysis, By Type, 2020-2027
9.2.6.4 Market size analysis, By Laboratory Type, 2020-2027
9.2.7 Research Dive Exclusive Insights
9.2.7.1 Market attractiveness
9.2.7.2 Competition heatmap
9.3 Asia-Pacific
9.3.1 China
9.3.1.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.1.2 Market size analysis, By Device Type, 2020-2027
9.3.1.3 Market size analysis, By Type, 2020-2027
9.3.1.4 Market size analysis, By Laboratory Type, 2020-2027
9.3.2 Japan
9.3.2.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.2.2 Market size analysis, By Device Type, 2020-2027
9.3.2.3 Market size analysis, By Type, 2020-2027
9.3.2.4 Market size analysis, By Laboratory Type, 2020-2027
9.3.3 India
9.3.3.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.3.2 Market size analysis, By Device Type, 2020-2027
9.3.3.3 Market size analysis, By Type, 2020-2027
9.3.3.4 Market size analysis, By Laboratory Type, 2020-2027
9.3.4 Australia
9.3.4.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.4.2 Market size analysis, By Device Type, 2020-2027
9.3.4.3 Market size analysis, By Type, 2020-2027
9.3.4.4 Market size analysis, By Laboratory Type, 2020-2027
9.3.5 South Korea
9.3.5.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.5.2 Market size analysis, By Device Type, 2020-2027
9.3.5.3 Market size analysis, By Type, 2020-2027
9.3.5.4 Market size analysis, By Laboratory Type, 2020-2027
9.3.6 Rest of Asia-Pacific
9.3.6.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.6.2 Market size analysis, By Device Type, 2020-2027
9.3.6.3 Market size analysis, By Type, 2020-2027
9.3.6.4 Market size analysis, By Laboratory Type, 2020-2027
9.3.7 Research Dive Exclusive Insights
9.3.7.1 Market attractiveness
9.3.7.2 Competition heatmap
9.4 LAMEA
9.4.1 Brazil
9.4.1.1 Market size analysis, By Distribution Channel, 2020-2027
9.4.1.2 Market size analysis, By Device Type, 2020-2027
9.4.1.3 Market size analysis, By Type, 2020-2027
9.4.1.4 Market size analysis, By Laboratory Type, 2020-2027
9.4.2 Saudi Arabia
9.4.2.1 Market size analysis, By Distribution Channel, 2020-2027
9.4.2.2 Market size analysis, By Device Type, 2020-2027
9.4.2.3 Market size analysis, By Type, 2020-2027
9.4.2.4 Market size analysis, By Laboratory Type, 2020-2027
9.4.3 UAE
9.4.3.1 Market size analysis, By Distribution Channel, 2020-2027
9.4.3.2 Market size analysis, By Device Type, 2020-2027
9.4.3.3 Market size analysis, By Type, 2020-2027
9.4.3.4 Market size analysis, By Laboratory Type, 2020-2027
9.4.4 South Africa
9.4.4.1 Market size analysis, By Distribution Channel, 2020-2027
9.4.4.2 Market size analysis, By Device Type, 2020-2027
9.4.4.3 Market size analysis, By Type, 2020-2027
9.4.4.4 Market size analysis, By Laboratory Type, 2020-2027
9.4.5 Rest of LAMEA
9.4.5.1 Market size analysis, By Distribution Channel, 2020-2027
9.4.5.2 Market size analysis, By Device Type, 2020-2027
9.4.5.3 Market size analysis, By Type, 2020-2027
9.4.5.4 Market size analysis, By Laboratory Type, 2020-2027
9.4.6 Research Dive Exclusive Insights
9.4.6.1 Market attractiveness
9.4.6.2 Competition heatmap
10. Competitive Landscape
10.1 Top winning strategies, 2020-2027
10.1.1 By strategy
10.1.2 By year
10.2 Strategic overview
10.3 Market share analysis, 2020-2027
11. Company Profiles
11.1 Abcam Plc.
11.1.1 Overview
11.1.2 Business segments
11.1.3 Product portfolio
11.1.4 Financial performance
11.1.5 Recent developments
11.1.6 SWOT analysis
11.2 US Biomax Inc.
11.2.1 Overview
11.2.2 Business segments
11.2.3 Product portfolio
11.2.4 Financial performance
11.2.5 Recent developments
11.2.6 SWOT analysis
11.3 Thermo Fisher Scientific
11.3.1 Overview
11.3.2 Business segments
11.3.3 Product portfolio
11.3.4 Financial performance
11.3.5 Recent developments
11.3.6 SWOT analysis
11.4 Bio-Rad Laboratories
11.4.1 Overview
11.4.2 Business segments
11.4.3 Product portfolio
11.4.4 Financial performance
11.4.5 Recent developments
11.4.6 SWOT analysis
11.5 Inc.
11.5.1 Overview
11.5.2 Business segments
11.5.3 Product portfolio
11.5.4 Financial performance
11.5.5 Recent developments
11.5.6 SWOT analysis
11.6 PerkinElmer Inc.
11.6.1 Overview
11.6.2 Business segments
11.6.3 Product portfolio
11.6.4 Financial performance
11.6.5 Recent developments
11.6.6 SWOT analysis
11.7 Philips Healthcare
11.7.1 Overview
11.7.2 Business segments
11.7.3 Product portfolio
11.7.4 Financial performance
11.7.5 Recent developments
11.7.6 SWOT analysis
11.8 Samsung Medison Co. Ltd.
11.8.1 Overview
11.8.2 Business segments
11.8.3 Product portfolio
11.8.4 Financial performance
11.8.5 Recent developments
11.8.6 SWOT analysis
11.9 Siemens Healthcare
11.9.1 Overview
11.9.2 Business segments
11.9.3 Product portfolio
11.9.4 Financial performance
11.9.5 Recent developments
11.9.6 SWOT analysis
11.10 Becton Dickinson and Company (BD)
11.10.1 Overview
11.10.2 Business segments
11.10.3 Product portfolio
11.10.4 Financial performance
11.10.5 Recent developments
11.10.6 SWOT analysis
11.11 Beckman Coulter Inc
11.11.1 Overview
11.11.2 Business segments
11.11.3 Product portfolio
11.11.4 Financial performance
11.11.5 Recent developments
11.11.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
